SCHEMBL24141283

SCHEMBL24141283

CC(C)(CO)c1ccc(-c2nc3cc(O)ccc3[nH]2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DGAT1 O75907 2/20 0.49
▸ KCNH2 Q12809 2/20 0.49
▸ HDAC6 Q9UBN7 2/20 0.48
▸ CHEK1 O14757 1/20 0.46
▸ PRKD3 O94806 1/20 0.46
▸ PAK4 O96013 1/20 0.46
▸ PDGFRA P16234 1/20 0.46
▸ LTK P29376 1/20 0.46
▸ MAP2K2 P36507 1/20 0.46
▸ MAPK8 P45983 1/20 0.46
▸ CDK8 P49336 1/20 0.46
▸ RPS6KA3 P51812 1/20 0.46
▸ PRKX P51817 1/20 0.46
▸ NEK2 P51955 1/20 0.46
▸ LIMK1 P53667 1/20 0.46
▸ CDK5 Q00535 1/20 0.46
▸ PRKCQ Q04759 1/20 0.46
▸ MAP4K2 Q12851 1/20 0.46
▸ ROCK1 Q13464 1/20 0.46
▸ LRRK2 Q5S007 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31027884 0.86 HDAC6 (0.64) DGAT1KCNH2HDAC6CHEK1PRKD3
SCHEMBL21705377 0.86 HDAC6 (0.64) DGAT1KCNH2HDAC6CHEK1PRKD3
SCHEMBL24141149 0.82 HDAC6 (0.71) HDAC6SCDKDM4ENPC1ALDH1A1
SCHEMBL5579984 0.81 CHEK1 (0.59) DGAT1KCNH2CHEK1PRKD3PAK4
SCHEMBL10579325 0.81 DGAT1 (0.51) DGAT1KCNH2HDAC6CHEK1PRKD3
SCHEMBL24141162 0.81 DGAT1 (0.48) DGAT1KCNH2HDAC6CHEK1PRKD3
SCHEMBL26816963 0.76 HDAC6 (0.57) DGAT1KCNH2HDAC6SCDNPBWR1
SCHEMBL2324234 0.75 NPC1 (0.62) HDAC6CHEK1PRKD3PAK4PDGFRA
SCHEMBL10577324 0.75 DGAT1 (0.46) DGAT1KCNH2HDAC6CHEK1PRKD3
SCHEMBL415254 0.75 CHEK1 (0.55) DGAT1KCNH2CHEK1PRKD3PAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024105635-A1 USES OF ZLN-005 AND RELATED COMPOUNDS KYOTO PREFECTURAL UNIVERSITY OF MEDICINE (JP) 2024-05-23 — — WO disclosed
WO-2023244685-A1 TREATMENT OF AGING-RELATED CHANGES AND DISEASES TRANQUIS THERAPEUTICS, INC. (US) 2023-12-21 — — WO disclosed
WO-2023205401-A1 TREATMENT OF DISEASES ASSOCIATED WITH REDUCTIVE STRESS Rdiscovery, LLC (US) 2023-10-26 — — WO disclosed
WO-2023081656-A1 SELECTION AND TREATMENT OF SUBJECTS HAVING A CIRCULATING MYELOID CELL INFLAMMATORY PHENOTYPE TRANQUIS THERAPEUTICS, INC. (US) 2023-05-11 — — WO disclosed
WO-2021262617-A1 TREATMENT OF SYSTEMIC IMMUNE ACTIVATION SYNDROMES TRANQUIS THERAPEUTICS, INC. (US) 2021-12-30 — — WO disclosed
Send feedback